Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer.
Kanlikilicer P, Bayraktar R, Denizli M, Rashed MH, Ivan C, Aslan B, Mitra R, Karagoz K, Bayraktar E, Zhang X, Rodriguez-Aguayo C, El-Arabey AA, Kahraman N, Baydogan S, Ozkayar O, Gatza ML, Ozpolat B, Calin GA, Sood AK, Lopez-Berestein G.
Kanlikilicer P, et al. Among authors: bayraktar e.
EBioMedicine. 2024 Dec 4;111:105486. doi: 10.1016/j.ebiom.2024.105486. Online ahead of print.
EBioMedicine. 2024.
PMID: 39637523
Free PMC article.
No abstract available.